Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

       
Total article views   HTML views PDF downloads Totals
11,847 Dovepress* 11,048+ 1,868 12,916
PubMed Central* 799 389 1,188
Totals 11,847 2,257 14,104
*Since 25 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar